Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

We conducted a phase III study to test the hypothesis that initial therapy with “lower dose” prednisone is effective and safe for patients with newly diagnosed acute graft-versus-host disease. We hypothesized that a 50% decrease in the initial dose of prednisone for treatment of acute graft-versus-h...

Full description

Bibliographic Details
Published in:	Haematologica
Main Authors:	Marco Mielcarek, Terrence Furlong, Barry E. Storer, Margaret L. Green, George B. McDonald, Paul A. Carpenter, Mary E.D. Flowers, Rainer Storb, Michael Boeckh, Paul J. Martin
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2015-06-01
Online Access:	https://haematologica.org/article/view/7415

Similar Items

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease
by: Yoshihiro Inamoto, et al.
Published: (2014-02-01)

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801
by: Paul A. Carpenter, et al.
Published: (2018-11-01)

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
by: Giancarlo Fatobene, et al.
Published: (2019-04-01)

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs
by: Hirohisa Nakamae, et al.
Published: (2011-12-01)

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect
by: Enrico Maffini, et al.
Published: (2018-06-01)

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms
by: Federico Monaco, et al.
Published: (2019-06-01)

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
by: Damian J. Green, et al.
Published: (2017-11-01)

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease
by: Yoshihiro Inamoto, et al.
Published: (2014-10-01)

Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: A double‐blind randomized trial
by: Mariola B. Rak, et al.
Published: (2023-03-01)

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
by: Yoshihiro Inamoto, et al.
Published: (2020-01-01)

Carbamazepine Rash and Prednisone
by: J Gordon Millichap
Published: (1991-02-01)

Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991-04-01)

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study
by: Joseph Pidala, et al.
Published: (2012-03-01)

Prednisone Therapy for Duchenne Dystrophy
by: J Gordon Millichap
Published: (2005-02-01)

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation
by: Joshua T. Schiffer, et al.
Published: (2009-08-01)

A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial
by: Qiaomei He, et al.
Published: (2024-05-01)

Prednisone for Acute Complex Regional Pain Syndrome: A Retrospective Cohort Study
by: Andrew Jamroz, et al.
Published: (2020-01-01)

Study on the anaerobic biotreatment of prednisone wastewater
by: TU Zhan, et al.
Published: (2007-03-01)

Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-06-01)

Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
by: Xiao-Lu Zhu, et al.
Published: (2022-04-01)

Patient-reported treatment response in chronic graft-<i>versus</i>-host disease
by: Annie Im, et al.
Published: (2023-05-01)

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease
by: Jeanne Palmer, et al.
Published: (2015-05-01)

Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone
by: Yixin Hu, et al.
Published: (2012-01-01)

Optimising prednisolone or prednisone replacement in adrenal insufficiency
by: Angelica Sharma, et al.
Published: (2023-07-01)

Effects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysis,
by: Thiago Mamôru Sakae, et al.
Published: (2014-10-01)

Effects of High-Dose Prednisone on the Gastrointestinal Microbiota of Healthy Dogs
by: Sarah Garrity, et al.
Published: (2025-03-01)

Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL/lpr mice
by: Zhengyang Zhu, et al.
Published: (2025-03-01)

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

Durable discontinuation of systemic therapy in patients affected by chronic graft-<i>versus</i>-host disease
by: George L. Chen, et al.
Published: (2022-05-01)

Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH).
by: Joseph Pidala, et al.
Published: (2024-01-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

EFFECTS OF IMIDOPYRAN AND PREDNISONE IN THE TREATMENT OF BABESIOSIOSIS-ASSOCIATED ANEMIA IN DOGS
by: NEVIDNYK-PRAVDA A.Y.
Published: (2023-04-01)

Pengaruh Prednison terhadap Perbaikan Pendengaran Penderita Lupus Eritematosus
by: Wijana, et al.
Published: (2016-06-01)

Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study
by: Junnan Su, et al.
Published: (2023-12-01)

P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
by: R. Steiner, et al.
Published: (2022-06-01)

Enhancing Prednisone-Based Arthritis Therapy with Targeted IL-27 Gene Delivery
by: Adriana A. Marin, et al.
Published: (2022-06-01)

Collagen Membranes for Host-Graft Integration: An Animal Study
by: Edwin Ravanzo Guerzon, et al.
Published: (2011-08-01)

Patient-reported outcomes and health status associated with chronic graft-versus-host disease
by: Stephanie J. Lee, et al.
Published: (2018-09-01)

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients
by: Paul J. Bröckelmann, et al.
Published: (2025-08-01)